Track topics on Twitter Track topics that are important to you
Shenzhen Tisenc Medical Equipment, a China point-of-care testing company, completed a $12 million Series B round led by Qiming Venture Partners, which also led the $6 million Series A round. Founded in 2015, Tisenc is a China-foreign JV that offers single-use point-of-care automatic chemiluminescence (CLIA) analyzers and more than 100 matching in vitro diagnostic reagents. The company says its innovative ACCRE system can serve in emergency departments, STAT laboratories and core laboratories. Tisenc will use the proceeds of the funding to advance its R&D, increase production capacity and expand global marketing. More details....
Share this with colleagues: